The following information is provided to assist the reader in understanding technologies disclosed below and the environment in which such technologies may typically be used. The terms used herein are not intended to be limited to any particular narrow interpretation unless clearly stated otherwise in this document. References set forth herein may facilitate understanding of the technologies or the background thereof. The disclosure of all references cited herein are incorporated by reference.
As part of the advancements of medicine and various medical treatments and procedures, there are an increased number of percutaneous ports and uses of percutaneous ports. Examples of percutaneous ports or lines include, but are not limited to, drivelines for Ventricular Assist Devices (VAD), feeding tubes, drain tubes, dialysis tubes, and catheters (sometime referred to herein collectively as “percutaneous lines”). These percutaneous lines may be in place for extended periods of time and often remain in use even after a patient leaves the hospital and returns to a home environment. The dressings utilized around the percutaneous opening are often makeshift, not very secure and not easy changed. Moreover, such dressings cannot be easily worn while bathing or showering.
Furthermore, such dressings are a source of skin irritations (from, for example, skin-adhering dressing adhesive area(s)) and do not adequately protect against various types of infections. Infections have become a major concern for hospital patients and those that may be in recovery from surgery. Patients having long-term percutaneous ports are particularly prone to infection.
VADs used today need to be powered by an external power source, usually electrical or pneumatic, via a driveline that contains electrical wire and/or tubing that is connected to an implanted blood pumping device and exits the body via a percutaneous hole in the abdomen. The exit point is a key concern, particularly as an entry point for infection causing microorganisms. Such infections are often sufficiently serious to cause extended hospital stays and even death. It has been stated that a third of the mortalities of patients having a VAD are directly related to infections beginning at the entry site of the driveline.
VAD driveline sheaths may include a velour type of cuff material at the entry site that facilitates skin in-growth into the velour, thus creating a seal of the opening. However, in-growth can take time (for example, on the order of weeks), requires complete immobilization of the driveline while skin in-growth is occurring, and can sustain damage by any accidental pulling/pushing of the driveline causing it to be torn away from the in-grown skin.
In one aspect, a port guard dressing for use in connection with skin of a patient and through which a percutaneous line can pass includes an upper component, a lower component adapted to contact the skin, and at least one intermediate component positioned between the upper component and the lower component. The at least one intermediate component is attached to a lower surface of the upper component and includes or is formed from a material that is more rigid than the upper component. The material of the intermediate component may also be more rigid than the lower component.
The port guard dressing may further include at least one absorbent component positioned below the at least one intermediate component and above the lower component. The absorbent component may, for example, include a hydroscopic material. In a number of embodiments, the absorbent component includes at least one of absorptive fibers, an absorptive powder or an absorptive gel.
The lower component may, for example, include an antimicrobial material. The antimicrobial material may, for example, include at least one of silver, a silver compound, iodine, an iodine compound, tetracycline, an antimicrobial peptide, or a quaternary ammonium compound.
1111 In a number of embodiments, the upper component includes a passage through which the percutaneous line can pass and a slit in connection with the passage of the upper component and extending to a perimeter of the upper component. The first intermediate component may, for example, include a passage through which a percutaneous line can pass and a slit in connection with the passage of the intermediate component and extending to a perimeter of the intermediate component. The lower component may, for example, include a passage through which a percutaneous line can pass and a slit in connection with the passage of the lower component and extending to a perimeter of the lower component. The passage of the upper component, the passage of the intermediate component and the passage of the lower component may, for example, be in general alignment. In a number of embodiments, the slit of the intermediate component and the slit of the lower component are in general alignment and are offset from the slit of the upper component. In a number of other embodiments, all component slits are in general alignment, with generally no offset therebetween.
As described above, the port guard dressing may further include at least one absorbent component positioned below the at least one intermediate component and above the lower component. The absorbent component may, for example, include a passage through which a percutaneous line can pass and a slit in connection with the passage of the absorbent component and extending to a perimeter of the absorbent component. The passage of the absorbent component may, for example, be in general alignment with the passage of the upper component, the passage of the intermediate component and the passage of the lower component. In a number of embodiments, the slit of the absorbent component is in general alignment with the slit of the intermediate component and the slit of the lower component, while be offset from the slit of the upper component.
The upper component may, for example, include a first section including an adhesive on a lower surface thereof adjacent the slit of the upper component via which the upper component is adapted to be adhered to at least one of the intermediate component and the lower component after the percutaneous line is positioned to pass through the passage of the upper component, the passage of the intermediate component and the passage of the lower component via the slit of the intermediate component and the slit of the lower component. The first section may, for example, be covered with a first section of a removable layer.
In a number of embodiments, the upper component is adhered to at least one of the intermediate component and the lower component via an adhesive positioned on a lower surface of the upper component outside of the first section of the upper component during fabrication of the port guard dressing. The lower component may, for example, have an area larger than an area of the intermediate component, and the upper component may be adhered to the lower component during fabrication of the port guard dressing. In a number of embodiments, an area of the upper component is larger than an area of the intermediate component and an area of the lower component, and the upper component includes a second section including an adhesive on the lower surface thereof via which the port guard dressing is adapted to be attached to the skin of the patient. The second section may, for example, extend around a perimeter of the upper component. The second section may, for example, be covered with a second section of a removable layer. In a number of embodiments, the second section is formed to have areas without adhesive which are adapted to decrease skin irritation. The second section may, for example, include a plurality of openings formed therein which are adapted to decrease skin irritation. The openings may, for example, extend from a perimeter of the second section inward toward the passage of the first component.
In a number of embodiments, the upper component includes a plurality of holes therein and the intermediate component comprises a plurality of holes therein. The plurality of holes of the upper component may, for example, be generally aligned with the plurality of holes of the intermediate component. The plurality of holes of the upper component may, for example, have a diameter in the range of 0.06 to 0.5 inches, and the plurality of holes of the intermediate component may, for example, have a diameter in the range of 0.06 to 0.5 inches.
In a number of embodiments, the intermediate component includes an adhesive layer on a lower surface thereof.
In a number of embodiments, the lower component includes a layer of material adapted to contact the skin and a generally axially oriented cylindrical extending member which extends from the layer of material of the lower component through the passage of the intermediate component and the passage of the upper component. The extending member may, for example, include an axially extending slit therein in general alignment with the slit of the intermediate component and the slit of the lower component through which the percutaneous line may pass to be placed within the extending member. In a number of embodiments, the axially oriented cylindrical extending member is formed from a rectangular piece of material including tabs along the bottom thereof. The rectangular piece of material is rolled to form the extending member and inserted into the passage of the bottom layer, with the axially extending slit of the extending member and slit of the lower component in alignment. The tabs may be bent radially outward and attached to the lower component.
The port guard dressing may, for example, include a strip of material which is adapted to be wrapped around the extending member and the percutaneous line. The strip of material may, for example, include an adhesive or is self-adhering. The strip of material may, for example, be attached to the extending member at one end thereof. In a number of embodiments, the strip of material has an axial height in the range of 0.5 to 2.0 inches and a length in the range of 1.5 to 4.0 inches.
In another aspect, a port guard dressing for use in connection with skin of a patient and through which a percutaneous line can pass includes an upper component, a lower component adapted to contact the skin, and at least one intermediate component positioned between the upper component and the lower component. The upper component includes a passage through which the percutaneous line can pass and a slit in connection with the passage of the upper component and extending to a perimeter of the upper component. The at least one intermediate component includes a passage through which a percutaneous line can pass and a slit in connection with the passage of the intermediate component and extending to a perimeter of the intermediate component. The lower component includes a passage through which a percutaneous line can pass and a slit in connection with the passage of the lower component and extending to a perimeter of the lower component. The passage of the upper component, the passage of the intermediate component and the passage of the lower component are in general alignment. The slit of the intermediate component and the slit of the lower component are in general alignment, and the slit of the upper component is offset from the slit of the intermediate component and the slit of the lower component.
The upper component may, for example, include a first section including an adhesive on a lower surface thereof adjacent the slit of the upper component via which the upper component is adapted to be adhered to at least one of the intermediate component and the lower component after the percutaneous line is positioned to pass through the passage of the upper component, the passage of the intermediate component and the passage of the lower component via the slit of the intermediate component and the slit of the lower component. The first section may, for example, be covered with a first section of a removable layer.
The upper component may, for example, be adhered to at least one of the intermediate component and the lower component via an adhesive positioned on a lower surface of the upper component outside of the first section of the upper component during fabrication of the port guard dressing. The lower component may, for example, have an area larger than an area of the intermediate component, and the upper component may be adhered to each of the intermediate component and the lower component during fabrication of the port guard dressing. In a number of embodiments, an area of the upper component is larger than an area of the intermediate component and an area of the lower component and the upper component includes a second section including an adhesive on the lower surface thereof via which the port guard dressing is adapted to be attached to the skin of the patient. The second section extends around a perimeter of the upper component. The second section may, for example, be covered with a second section of a removable layer.
The second section may, for example, be formed to have areas without adhesive which are adapted to decrease skin irritation. The second section may, for example, include a plurality of openings formed therein which are adapted to decrease skin irritation. The openings may, for example, extend from a perimeter of the second section inward toward the passage of the first component.
In another aspect, a method of fabricating a port guard dressing for use in connection with skin of a patient and through which a percutaneous line can pass includes providing an upper component, providing a lower component adapted to contact the skin, providing at least one intermediate component positioned between the upper component and the lower component, attaching the at least one intermediate component to a lower surface of the upper component, the at least one intermediate component including a material that is more rigid than the upper component. The material of the intermediate component may also be more rigid than the lower component.
In another aspect, a method of fabricating a port guard dressing for use in connection with skin of a patient and through which a percutaneous line can pass includes providing an upper component, providing a lower component adapted to contact the skin, providing at least one intermediate component positioned between the upper component and the lower component, the upper component including a passage through which the percutaneous line can pass and a slit in connection with the passage of the upper component and extending to a perimeter of the upper component, the at least one intermediate component including a passage through which a percutaneous line can pass and a slit in connection with the passage of the intermediate component and extending to a perimeter of the intermediate component, and the lower component including a passage through which a percutaneous line can pass and a slit in connection with the passage of the lower component and extending to a perimeter of the lower component, the passage of the upper component, the passage of the intermediate component and the passage of the lower component being in general alignment, the slit of the intermediate component and the slit of the lower component being in general alignment, and the slit of the upper component being offset from the slit of the intermediate component and the slit of the lower component.
In a further aspect, a method of securing a percutaneous line includes use of a port guard dressing as set forth herein.
The present devices, systems, and methods, along with the attributes and attendant advantages thereof, will best be appreciated and understood in view of the following detailed description taken in conjunction with the accompanying drawings.
It will be readily understood that the components of the embodiments, as generally described and illustrated in the figures herein, may be arranged and designed in a wide variety of different configurations in addition to the described representative embodiments. Thus, the following more detailed description of the representative embodiments, as illustrated in the figures, is not intended to limit the scope of the embodiments, as claimed, but is merely illustrative of representative embodiments.
Reference throughout this specification to “one embodiment” or “an embodiment” (or the like) means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, the appearance of the phrases “in one embodiment” or “in an embodiment” or the like in various places throughout this specification are not necessarily all referring to the same embodiment.
Furthermore, described features, structures, or characteristics may be combined in any suitable manner in one or more embodiments. In the following description, numerous specific details are provided to give a thorough understanding of embodiments. One skilled in the relevant art will recognize, however, that the various embodiments can be practiced without one or more of the specific details, or with other methods, components, materials, et cetera. In other instances, well known structures, materials, or operations are not shown or described in detail to avoid obfuscation.
As used herein and in the appended claims, the singular forms “a,” “an”, and “the” include plural references unless the context clearly dictates otherwise. Thus, for example, reference to “a layer” includes a plurality of such layers and equivalents thereof known to those skilled in the art, and so forth, and reference to “the layer” is a reference to one or more such layers and equivalents thereof known to those skilled in the art, and so forth. Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range. Unless otherwise indicated herein, and each separate value, as well as intermediate ranges, are incorporated into the specification as if individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contraindicated by the text.
In addition, minimizing or eliminating the risk of infection, a port guard dressing for use in connection with a percutaneous line such as a VAD driveline is required to be in place for many days, weeks, if not for months or years. Such a port guard dressing should not only be able to be in place for extended periods of time, but should also be easily changed and maintained by personnel with minimal or no medical training. While providing a physical securement of the percutaneous line, the port guard dressing should also cause minimal, if any, discomfort from port site infections and skin irritations caused from the skin-adhesive portions of the dressing. In general, a port guard dressing should provide peace of mind to the patient and enable the patient to lead a life as close as possible to a “normal”, unencumbered way of life (including, for example, participation in the usual daily routines of bathing, showering, exercise, work, etc.).
Port guard dressings hereof greatly alleviate problems at the percutaneous entry site for percutaneous lines and/or other port applications. For example, port guard dressings hereof provide an actual physical barrier, which can be treated with an antibacterial coating, for preventing the passage of unwanted micro-organisms through the percutaneous opening. Further, port guard dressings hereof firmly secure the percutaneous line to the body to prevent unwanted movement relative to the body with respect to the driveline. One type of unwanted percutaneous line movement is inward and outward motion from the body. This type of motion not only poses a risk of damage to the percutaneous line and associated devices, but also may harm internal tissue and organs. The inward/outward movement of the percutaneous line also enables the dangerous entry of harmful, and in some cases lethal, infection causing micro-organisms, which may initially reside on the percutaneous line at the immediate entry site and will end up inside of the body when the percutaneous line is pushed into the body. Another type of unwanted motion, side-to-side motion of the percutaneous line, can cause an enlargement of the percutaneous entry hole, further increasing the risk of infection. In addition to the above mentioned benefits, the port guard dressings hereof enhance peace of mind of the patient by ensuring that the port line is secure with the entry point being hidden under the dressing and that the entry point is secured, sealed and protected from the outside elements.
In general, port guard dressings hereof include an upper component having an upper surface which is in contact with the surrounding environment and a lower component having a lower surface which is in contact with the skin of a patient when the port guard dressing is in use in connection with a patient. Terms such as up, down, upper, lower, above, below and like terms refer to an orientation of the port guard dressing as worn by the patient wherein upper is away from the patients skin and lower is toward the patients skin. The term radial and like terms refers to a direction generally perpendicular to an axis defined by an opening or passage in the port guard dressing through which a percutaneous port or line passes. The port guard dressings may be, but need not be, formed circularly and/or generally symmetrically about the opening or passage. The port guard dressing hereof also include one or more intermediate components positioned intermediate or between the upper component and the lower component. In the embodiment set forth in
In a number of embodiments, one or more components of port guard dressing 10 include layers or films of materials with an adhesive on at least one side thereof. The adhesive may, for example, be covered by a peel away layer that can be removed during assembly (to bond adjacent layers) or upon application to patient.
In
Vent holes 132 may be provided in layer 130 of first or upper component 100 to, for example, observe any blood or bodily fluids that may emanate from the percutaneous opening in the patient and/or to add of water and/other fluids to activate a antimicrobial coating that may be imparted on a fabric layer 430 of component 400 (discussed further below) for infection control. Such an antimicrobial coating may, for example, include a silver-based material, an iodine-based material, tetracycline, antimicrobial peptides materials, quaternary ammonium compounds and/or other anti-microbial inhibiting agents.
Second component 200 is an intermediate component which, in the illustrated embodiment, is positioned adjacent and below first component 100 in assembled port guard dressing 10. Vent hole 232 in second component 200 align with vent holes 132 in first component 100. In a number of embodiment, holes 232 were cut with second component 200 and first component 100 adhered together. Second component 200, as illustrated in
During assembly of port guard dressing 10, second component 200 is adhered to first component 100 by first removing peel away section 112 encompassed within dashed line 122, of
The slit and associated generally central passages of each of the components are aligned as illustrated in
The lower surface of second component 200, which is opposite the upper surface facing first component 100, may have an adhesive layer and a protective peel away layer (not shown). The peel away layer may be removed to expose adhesive for adhering second component 200 to third component 300, wherein second component 200 and third component 300 may be aligned so that slits 240 and 340 are in general alignment (and offset by angle α with respect to slit 140). Again, the slits may be precut and appropriately aligned during assembly or the slits can be cut after two, more than two or all the layers have been laminated together. In a number of embodiments, layer 300 is an absorbent layer that may, for example, be formed from cotton, polyester, polyurethane, or a mixture thereof. The absorbent material may include hydroscopic powder, gel and/or other material in the matrix thereof. In a number of embodiments third component 300 is formed from a porous, sponge-like material which can absorb fluids (for example, a porous cotton or polyurethane).
Fourth and bottom component 400 (see FIGS. 2 and 6-7B) is placed in direct contact with the skin and percutaneous opening in the skin. Component 400, which is slightly larger in diameter than second component 200 and third component 300 in the illustrated embodiment, may be attached or laminated to first component 100 using an adhesive layer on first component 100 exposed by removing section 114 of peel away layer 110, which is defined by dashed lines (cuts) 122 and 124, as bounded by dashed line 126 and slit 140 (see
Fourth component 400 may be constructed in a number of ways. For example, fourth component 400 may be made by weaving or knitting from a single, monolithic piece of material. Fourth component 400b may alternatively be made of fabricated from two (or more) pieces of material 430a and 470a as illustrated in
In assembled port guard dressing 10, the area of outer layer 130 between slit 140 and aligned slits 240, 340 and 440 as represented by arc α, provides an openable fold of material in outer layer 130 of upper component 100 (in operative association with aligned slits 240, 340 and 440) via which port guard dressing 10 can be placed in operative connection which a percutaneous line passing through the percutaneous opening in the patient (see, for example,
For attachment of port guard dressing 10 to the skin of the patient, outer section 118 of peel away layer 110 may be removed to expose an underlying adhesive layer or portion that adheres to the skin of the patient (see, for example,
It has been found that a primary reason for the irritation of skin from a dressing adhered to the skin for an extended period of time is the disconnect of elastic properties of the adhered dressing section and the skin. By, for example, placing slits or openings 136 (see, for example,
The use of slits or openings for the reduction of skin irritation of bandages or dressing can be used on other bandages or dressings of various shapes and sizes. A couple examples of common bandages 600 and 600a that display the irritation relieving slits or openings 636a and 636b, respectively, are shown in
In a number of representative embodiments of multi-component/multi-layer port guard dressings 10 hereof, first component 100 may, for example, have a diameter in the range of approximately 1.5 to 5.0 inches. Outer layer 130 of first component 100 may, for example, be fabricated from cloth, elastomeric plastic, nonwoven or other material that is suitable as an upper dressing layer. As described above, second component 200 is more rigid and/or stiffer that first component 100 to provide stiffness and mechanical strength and may, for example, be fabricated from a polymeric material. Second component 200 may, for example, be in the range of approximately 0.05 mm to 1.6 mm inches in thickness and have a diameter in the range of approximately 1 to 3 inches. Absorbent, third component 300 (which may, for example, be formed of cotton, a polymer such as a polyester, or other fabrics or blends of fabrics, whether woven or non-woven) may include a fluid absorbing powder, gel, fibers or other material for absorbing water-based body fluids and/or providing water for activating any anti-microbial coating that may be incorporated in fourth component 400. Third component 300 may, for example, have a diameter that is the same or slightly smaller than second component 200, and smaller than a diameter of bottom, fourth component 400. Fourth component 400 may, for example, have a diameter in the range of approximately 1.0 to 3.25 inches and which is intermediate between the diameters of first component 100 and second component 200. Generally tubular or cylindrical extending member 470 of fourth component 400 may, for example, be approximately 0.5 to 2.0 inches in length and may be formed of the same material or fabric of layer 430 of fourth component 400. As discussed above, extending member 470 may, for example, assist in supporting or holding the tube or line that passes into the body through the percutaneous hole.
The foregoing description and accompanying drawings set forth a number of representative embodiments at the present time. Various modifications, additions and alternative designs will, of course, become apparent to those skilled in the art in light of the foregoing teachings without departing from the scope hereof, which is indicated by the following claims rather than by the foregoing description. All changes and variations that fall within the meaning and range of equivalency of the claims are to be embraced within their scope.
This application claims benefit of U.S. Provisional Patent Application Ser. No. 62/024,245, filed Jul. 14, 2014, the disclosure of which is incorporated herein by reference.
This invention was made with government support under grant nos. 2R44HL106929-02 and R44HL106929-03 awarded by the National Heart, Lung and Blood Institute of the National Institutes of Health. The government has certain rights in this invention.
Number | Date | Country | |
---|---|---|---|
62024245 | Jul 2014 | US |